PoisoningNCT02553070
Health Professions Students and Faculty Perceptions of Poisoning Severity
An observational study of Poisoning, run by University of Florida at 1 site in United States.
Trial summary
Inaccurate perceptions of the severity of an exposure may result in unnecessary visits to the Emergency Department or Health Care Facility which can result in crowding of Emergency Departments, unnecessary utilization of valuable health care resources, unnecessary treatments, and or mistakes / errors resulting in harm… Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Poisoning
- What is being tested?
- Survey
- How many people
- 1,000 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2015to Nov 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Pharmacy students in their 1st or 2nd year of pharmacy school.
Who may be able to join
- All pharmacy students who agree to participate
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Florida College of Pharmacy
Gainesville, Florida, 32610
About this study
Official title: Health Professions Students and Facutly Perceptions of Poisoning Severity
Inaccurate perceptions of the severity of an exposure may result in unnecessary visits to the Emergency Department or Health Care Facility which can result in crowding of Emergency Departments, unnecessary utilization of valuable health care resources, unnecessary treatments, and or mistakes / errors resulting in harm to the patient.
Inaccurate perceptions about the severity of an exposure can result in delays in proper evaluation and treatment resulting in harm or in some cases death of the patient.
Read the detailed description
Consumers and health professionals are often surprised about the toxicity (or lack of toxicity) after exposure to a number of pharmaceutical or non-pharmaceutical agents. Past experience with the survey used in this study has indicated that consumers and health professional perform about the same. Most individuals answer less than 50% of questions incorrectly.
Pharmacy students will be asked to participate in a short (5-7 minutes) survey (see below) that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. All cases involve children less than 19 years of age. Participants will be asked to indicate their year in pharmacy school (1st or 2nd) and their gender (f/m). The survey will be given after a scheduled examination or other classroom activity and will not involve class time. Students will be provided a link to an online version of the survey.
Conclusions will be derived through the analysis of the data. At a later date, all students in the class (whether they participated in the survey or not)students will be provided a link to video that describes the correct answers to each of the cases and an explanation.
- Conditions
- Poisoning
- Being tested
- Survey
- Medical subject headings
- Poisoning
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
Pharmacy students will be asked to participate in a short (5-7 minutes) survey (see below) that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. All cases involve children less than 19 years of age. Participants will be asked to indicate their year in pharmacy school (1st or 2nd) and their gender (female/male).
| Study group | Role | What they receive |
|---|---|---|
| Pharmacy Students | Participants will be asked to indicate their perception of poisoning severity by answering a short survey. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Survey will be used for perceptions of poisoning severity
Pharmacy students will be asked to participate in a short (5-7 minutes) survey that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. The survey will consist of two answers, either "Hospital" or "Home". The data will be complied using the percentage of correct answers on the poisoning severity.
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Sep 2015 (estimated)
- Study startSep 2015
- Primary completionOct 2015
- Study completionNov 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PoisoningStudies of the same condition, open and under way.
- More trials run by University of FloridaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sven A Normann, PharmD, Principal investigator, University of Florida
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02553070
- Sponsor's protocol ID
- IRB201500799
- Status last verified
- Nov 2015
- First submitted
- 16 Sep 2015
- Last updated
- 13 Nov 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Nov 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Professions Students and Facutly Perceptions of Poisoning Severity
- ClinicalTrials.gov ID
- NCT02553070
- Acronym / sponsor ID
- IRB201500799
- Conditions
- Poisoning
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,000 participants (actual)
- Lead sponsor
- University of FloridaUniversity, hospital or other
- Study start
- Sep 2015
- Primary completion
- Oct 2015 (actual)
- Study completion
- Nov 2015 (actual)
- First posted
- 17 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Inaccurate perceptions of the severity of an exposure may result in unnecessary visits to the Emergency Department or Health Care Facility which can result in crowding of Emergency Departments, unnecessary utilization of valuable health care resources, unnecessary treatments, and or mistakes / errors resulting in harm to the patient.
Inaccurate perceptions about the severity of an exposure can result in delays in proper evaluation and treatment resulting in harm or in some cases death of the patient.
Detailed description
Consumers and health professionals are often surprised about the toxicity (or lack of toxicity) after exposure to a number of pharmaceutical or non-pharmaceutical agents. Past experience with the survey used in this study has indicated that consumers and health professional perform about the same. Most individuals answer less than 50% of questions incorrectly.
Pharmacy students will be asked to participate in a short (5-7 minutes) survey (see below) that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. All cases involve children less than 19 years of age. Participants will be asked to indicate their year in pharmacy school (1st or 2nd) and their gender (f/m). The survey will be given after a scheduled examination or other classroom activity and will not involve class time. Students will be provided a link to an online version of the survey.
Conclusions will be derived through the analysis of the data. At a later date, all students in the class (whether they participated in the survey or not)students will be provided a link to video that describes the correct answers to each of the cases and an explanation.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pharmacy Students | – | Other: SurveyParticipants will be asked to indicate their perception of poisoning severity by answering a short survey. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Pharmacy students in their 1st or 2nd year of pharmacy school.
Key inclusion criteria (1 listed)
- All pharmacy students who agree to participate
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyPharmacy students will be asked to participate in a short (5-7 minutes) survey (see below) that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. All cases involve children less than 19 years of age. Participants will be asked to indicate their year in pharmacy school (1st or 2nd) and their gender (female/male). | Other | Pharmacy Students |
Primary outcome
Survey will be used for perceptions of poisoning severity
Time frame: Day 1
Pharmacy students will be asked to participate in a short (5-7 minutes) survey that contains 21-short cases involving an exposure to a pharmaceutical or non-pharmaceutical agent. The survey will consist of two answers, either "Hospital" or "Home". The data will be complied using the percentage of correct answers on the poisoning severity.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Nov 2015.
Related trials for Poisoning
Not yet recruitingPhase 2
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Colorectal Cancer, Liver Metastases
Recruiting
Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on Children
Tick Bites
RecruitingObservational study
Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance
Obstructive Sleep Apnea Syndrome
Active, not recruitingPhase 1
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
Small Cell Lung Carcinoma
RecruitingPhase 3
Assessment of The Potential Therapeutic Effects of Trimetazidine on Aluminium Phosphide-Induced Cardiotoxicity as an Adjuvant Therapy: A Pilot Study
Aluminum Phosphide Poisoning
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sven A Normann, PharmD principal investigator
University of Florida
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Poisoning, run by University of Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Nov 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Survey will be used for perceptions of poisoning severity (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2015.